Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2010
07/21/2010CN1976910B Novel 2,4-diaminothiazol-5-one derivatives
07/21/2010CN1960977B Quinazoline derivative
07/21/2010CN1784983B Method for producing wheat flour with functions of lowering blood-sugar and blood-fat
07/21/2010CN101784543A Indole and indazole compounds as an inhibitor of cellular necrosis
07/21/2010CN101784536A Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
07/21/2010CN101784528A Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
07/21/2010CN101784270A Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative
07/21/2010CN101781361A Balsam pear MC-JJ2163 polypeptide analogs by microwave-enhanced solid-phase synthesis and application thereof
07/21/2010CN101781330A Propofol, phosphate and amino acid double salt and preparation method and application thereof
07/21/2010CN101781287A Irbesartan hydrobromide and preparation method thereof
07/21/2010CN101780271A Medicinal composition of endotoxin and lectin and application thereof
07/21/2010CN101780268A Method and reagent for diagnosing, preventing and treating insulin resistance
07/21/2010CN101780251A Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof
07/21/2010CN101780242A Health or medicine composite and preparation method and application thereof
07/21/2010CN101780232A Coix seed oil proliposome and preparation method thereof
07/21/2010CN101780215A Refining method of traditional Chinese medicine composition water extract containing ginseng
07/21/2010CN101780200A Tibetan and Chinese saffron and peach kernel lipid-lowering pill and capsule
07/21/2010CN101780192A External Chinese medicine for curing gangrene caused by diabetes
07/21/2010CN101780184A Application of nutrition combination in preparation of medicine for restoring mismatch repair gene damage
07/21/2010CN101780181A Nitric oxide free radical health care product
07/21/2010CN101780156A Medicine for curing glucose regulation impairment and preparation method thereof
07/21/2010CN101780155A Application of medicament containing liquorice and radix paeoniae alba in preparing synergistic medicament for treating diabetes
07/21/2010CN101780147A Anti-inflammatory and hypoglycemic mulberry leave extract and preparation method of preparation thereof
07/21/2010CN101780140A Drug for treating cardiovascular and cerebrovascular diseases and preparation method thereof
07/21/2010CN101780135A Milkvetch root extract, preparation method and application thereof
07/21/2010CN101780095A Antidiabetic formulation and method
07/21/2010CN101780081A Niacin and simvastatin composition sustained-release tablet
07/21/2010CN101780070A Pharmaceutical composition for treating diabetic nephropathy and preparation method and application thereof
07/21/2010CN101780069A Drug composite for preventing diabetic nephropathy and preparation method thereof
07/21/2010CN101780067A Pharmaceutical composition for treating diabetic nephropathy and preparation method and application
07/21/2010CN101780049A Enteric solid preparation using feinuobeite acid and feinuobeite salt as major ingredients and preparation method thereof
07/21/2010CN101537012B Complex vitamin freeze-dried powder injection and preparation method thereof
07/21/2010CN101385730B Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof
07/21/2010CN101385729B Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof
07/21/2010CN101352426B Osmotic pump controlled release preparation composition and preparation thereof
07/21/2010CN101284001B Application of mangiferin in treating type II diabetes and vitro trial model thereof
07/21/2010CN101167904B Medicinal composition for treating hyperlipemia and its preparing process
07/21/2010CN101121004B Medicine composition containing insulin intensifier and miglitol
07/21/2010CN101069745B Medicine composition for treating 2-type diabetes
07/20/2010US7759496 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
07/20/2010US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
07/20/2010US7759333 pentaazacycle manganese complexes, as mimetics for oxidoreductase enzymes,used for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects
07/20/2010US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor
07/20/2010CA2607848C 3-substituted (3-phenyl)-propionic acid derivatives for the treatment of metabolic disorders
07/20/2010CA2547234C The use of quaternary pyridinium salts as vasoprotective agents
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2454732C Drugs for ameliorating postcibal hyperglycemia
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
07/20/2010CA2378106C Bioavailable chelates of creatine and essential metals
07/20/2010CA2322487C Novel prodrugs for phosphorus-containing compounds
07/20/2010CA2246733C Use of a pharmaceutical composition comprising an appetite-suppressing peptide
07/20/2010CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
07/15/2010WO2010081079A2 Composition and method for treatment of diabetes
07/15/2010WO2010080756A2 Harmine derivatives for reducing body weight
07/15/2010WO2010080730A2 Methods and materials for delivering bile acids
07/15/2010WO2010080333A1 Arylcyclopropylacetamide derivatives useful as glucokinase activators
07/15/2010WO2010079910A2 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
07/15/2010WO2010079819A1 Pharmaceutical composition for treating obesity or diabetes
07/15/2010WO2010079668A1 Olefin compound
07/15/2010WO2010079428A2 Biomarkers for appetite regulation
07/15/2010WO2010079197A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
07/15/2010WO2010078842A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
07/15/2010WO2010078659A1 Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions
07/15/2010WO2010059602A3 Inhibitors of diacylglycerol acyltransferase
07/15/2010WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof
07/15/2010WO2010041908A3 Novel use of panduratin derivative or boesenbergia pandurata extract
07/15/2010WO2010029513A3 Pcsk9 antagonists
07/15/2010WO2009158412A3 Sustained delivery of exenatide and other polypeptides
07/15/2010WO2009149058A8 Modified release niacin formulations
07/15/2010US20100179304 Somatostatin-Dopamine Chimeric analogs
07/15/2010US20100179224 Acyclic Sulfamide Derivatives
07/15/2010US20100179183 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
07/15/2010US20100179173 Substituted fused pyrimidines as antagonists of gpr105 activity
07/15/2010US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
07/15/2010US20100179158 Inhibitors of cyclic amp phosphodiesterases
07/15/2010US20100179146 Indolinone Compounds as Kinase Inhibitors
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179140 Indenoisoquinolinone analogs and methods of use thereof
07/15/2010US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
07/15/2010US20100179138 Isozazole Compounds As Inhibitors Of Heat Shock Proteins
07/15/2010US20100179131 Combination treatment for diabetes mellitus
07/15/2010US20100179129 Compositions of an anticonvulsant and mirtazapine to prevent weight gain
07/15/2010US20100179128 Xanthine derivatives as selective hm74a agonists
07/15/2010US20100179123 Thienopyrimidines useful as aurora kinase inhibitors
07/15/2010US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold
07/15/2010US20100179113 Stanol composition and the use thereof
07/15/2010US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
07/15/2010US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases
07/15/2010US20100179093 Neoropeptide-2-Receptor (Y-2R) Agonists
07/15/2010US20100179090 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
07/15/2010US20100178371 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 1298